Dan Li

ORCID：0000-0003-0324-2753

发表论文 63 篇 · 总被引 1178 次 · h-index 15

代表论文

• Data from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer (2025 · 被引 1)
• Supplementary Fig. S3 from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer (2026)
• Supplementary Fig. S5 from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer (2026)
• Supplementary Fig. S10 from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer (2026)
• Supplementary Table S4 from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer (2026)
• Supplementary Fig. S2 from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer (2026)